DAFTAR PUSTAKA

1. MENKES RI. 2008. Pedoman Pengendalian Penyakit Paru Obstruktif Kronik.

Jakarta.
2. Susanti, PFE. 2015. Pengaruh Merokok Terhadap Penyakit Paru Obstruktif
Kronik. Fakultas Kedokteran Universitas Lampung. J Majority: vol 4 no 5
3. PDPI. 2011. Penyakit Paru Obstruktif Kronik (PPOK): Pedoman Diagnosis dan
Penatalaksanaan di Indonesia. Perhimpunan Dokter Paru Indonesia. Jakarta.
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global
Strategy for The Diagnosis, Management, and Prevention of Chronic
Obstructive Pulmonary Disease. Update 2017.
5. Senior RM, Atkinson JJ. 2008. Chronic Obstructive Pulmonary Disease:
Epidemiology, Pathofisiology, and Pathogenesis. Fishman’s Pulmonary
Disease and Disorders. 4th eds. Newyork: The McGraw Hill Companies: 707-
28
6. PDPI. 2010. Penyakit Paru Obstruktif Kronik (PPOK): Pedoman Diagnosis dan
Penatalaksanaan di Indonesia. Perhimpunan Dokter Paru Indonesia. Jakarta.
7. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD
in a longitudinal study. Chest 2004; 126(1): 59-65.
8. Aida M. Yousef, Wael Alkhiary. Role of neutrophil to lymphocyte ratio in
prediction of acute exacerbation of chronic obstructive pulmonary disease.
Egyptian Journal of Chest Diseases and Tuberculosis (2017) 66, 43–48.
9. Attiya Siddiqi, Sanjay Sethi. Optimizing antibiotic selection in treating COPD
Exacerbations. International Journal of COPD 2008:3(1)
10. Lystra P. Hayden et all. Childhood pneumonia increases risk for chronic
obstructive pulmonary disease: the COPD Gene study. Hayden et al.
Respiratory Research (2015) 16:115
11. Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin maintenance treatment
in patients with frequent exacerbations of chronic obstructive pulmonary disease
(COLUMBUS): a randomised, double- blind, placebo-controlled trial. The
Lancet Respiratory medicine 2014; 2(5): 361-8.
12. Decramer M, Rutten-van Mo¨ lken M, Dekhuijzen PR, Troosters T, van
Herwaarden C, Pellegrino R, van Schayck CO, Olivieri D, Del Donno M, De
Backer W, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive
pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study,

1
 BRONCUS): a randomised placebo-controlled trial. Lancet 2005;365:1518–
1520.
13. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes
NC. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane
Database Syst Rev 2006; (2): CD004403.
14. Lionel A. Mandell, et al. Infectious Diseases Society of America/American
Thoracic Society Consensus Guidelines on the Management of Community-
Acquired Pneumonia in Adults. IDSA/ATS Guidelines for CAP in Adults • CID
2007:44